Clinical Trials

Showing trials with last updates posted in 2026.

NCT07574541 | NOT_YET_RECRUITING | PHASE2
52 participants

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-09-09
Completion:
2027-06-15
Conditions
  • Adenocarcinoma
  • Prostate Cancer
  • Neoplasms
  • Carcinoma
  • Neoplasms, Glandular and Epithelial
  • Neoplasms by Histologic Type
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT07562152 | RECRUITING | PHASE3
510 participants

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-06-05
Completion:
2028-06-30
Conditions
  • Pancreatic Cancer
  • Pancreatic Cancer Metastatic
  • PDAC
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Adenocarcinoma
Interventions
  • DRUG
No Results Yet
NCT07535827 | COMPLETED | EARLY_PHASE1
50 participants

Insulin Intratympanic Application

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-03-20
Completion:
2026-05-15
Conditions
  • Tympanic Membrane Perforation
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT07516366 | RECRUITING | PHASE2
16 participants

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2027-05-17
Completion:
2028-12-31
Conditions
  • Clear Cell Renal Cell Carcinoma
  • Stage II Renal Cell Cancer AJCC v8
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT07512596 | RECRUITING | PHASE2
48 participants

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-07-21
Completion:
2027-07-31
Conditions
  • Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page